XML 141 R122.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SEGMENT REPORTING - Schedule of Reportable Segment Information and Reconciliation of Segment Information (Details) - USD ($)
$ in Millions
12 Months Ended 24 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2024
Segment Reporting Information [Line Items]        
Net Sales $ 7,093 $ 7,389 $ 7,107  
Interest income 23 16 5  
Interest expense (90) (90) (106)  
Loss on divestiture (240) 0 0  
Pension settlement charge (171) 0 0  
Cyberattack costs, net of insurance recoveries (29) 0 0  
VMS impairment 0 (445) 0  
Streamlined operating model (32) (60) 0  
Digital capabilities and productivity enhancements investment (108) (100) (61)  
Earnings (losses) before income taxes 398 238 607  
(Income) Loss from equity investees included in Other (income) expense, net (5) (4) (6)  
Total assets 5,751 5,945   $ 5,751
Capital expenditures 212 228 251  
Depreciation and amortization 235 236 224  
Stock-based compensation $ 74 $ 73 52  
Cyberattack | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 100.00%      
Restructuring and Related Costs Benchmark | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 100.00% 100.00%   100.00%
Operating Segments        
Segment Reporting Information [Line Items]        
Net Sales $ 6,872 $ 7,149 6,844  
Segment adjusted earnings (losses) before interest and income taxes 1,354 1,275 992  
Operating Segments | Health and Wellness        
Segment Reporting Information [Line Items]        
Net Sales 2,485 2,532 2,427  
Segment adjusted earnings (losses) before interest and income taxes 719 594 381  
(Income) Loss from equity investees included in Other (income) expense, net 0 0 0  
Total assets 1,124 1,184   $ 1,124
Capital expenditures 47 51 61  
Depreciation and amortization 58 59 57  
Stock-based compensation $ 14 $ 14 14  
Operating Segments | Health and Wellness | Cyberattack | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 30.00%      
Operating Segments | Health and Wellness | Restructuring and Related Costs Benchmark | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 3.00% 6.00%   5.00%
Operating Segments | Household        
Segment Reporting Information [Line Items]        
Net Sales $ 1,950 $ 2,098 1,984  
Segment adjusted earnings (losses) before interest and income taxes 260 308 234  
(Income) Loss from equity investees included in Other (income) expense, net 0 0 0  
Total assets 1,088 1,082   $ 1,088
Capital expenditures 84 97 112  
Depreciation and amortization 77 78 67  
Stock-based compensation $ 11 $ 10 8  
Operating Segments | Household | Cyberattack | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 24.00%      
Operating Segments | Household | Restructuring and Related Costs Benchmark | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 2.00% 1.00%   2.00%
Operating Segments | Lifestyle        
Segment Reporting Information [Line Items]        
Net Sales $ 1,275 $ 1,338 1,253  
Segment adjusted earnings (losses) before interest and income taxes 253 284 280  
(Income) Loss from equity investees included in Other (income) expense, net 0 0 0  
Total assets 1,110 1,091   $ 1,110
Capital expenditures 36 29 24  
Depreciation and amortization 24 25 24  
Stock-based compensation $ 8 $ 7 6  
Operating Segments | Lifestyle | Cyberattack | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 23.00%      
Operating Segments | Lifestyle | Restructuring and Related Costs Benchmark | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 0.00% 4.00%   2.00%
Operating Segments | International        
Segment Reporting Information [Line Items]        
Net Sales $ 1,162 $ 1,181 1,180  
Segment adjusted earnings (losses) before interest and income taxes 122 89 97  
(Income) Loss from equity investees included in Other (income) expense, net (5) (4) (6)  
Total assets 1,327 1,410   $ 1,327
Capital expenditures 21 24 27  
Depreciation and amortization 45 46 47  
Stock-based compensation $ 6 $ 4 3  
Operating Segments | International | Cyberattack | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 8.00%      
Operating Segments | International | Restructuring and Related Costs Benchmark | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 4.00% 16.00%   11.00%
Corporate and Other        
Segment Reporting Information [Line Items]        
Net Sales $ 221 $ 240 263  
Segment adjusted earnings (losses) before interest and income taxes (309) (358) (223)  
(Income) Loss from equity investees included in Other (income) expense, net 0 0 0  
Total assets 1,102 1,178   $ 1,102
Capital expenditures 24 27 27  
Depreciation and amortization 31 28 29  
Stock-based compensation $ 35 $ 38 21  
Corporate and Other | Cyberattack | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 15.00%      
Corporate and Other | Restructuring and Related Costs Benchmark | Product Concentration Risk        
Segment Reporting Information [Line Items]        
Concentration percentage 91.00% 73.00%   80.00%
Operating Segments and Corporate and Other        
Segment Reporting Information [Line Items]        
Segment adjusted earnings (losses) before interest and income taxes $ 1,045 $ 917 $ 769